Paper39196440
Inflammatory aspects of Alzheimer's disease.
Botella Lucena P and 1 other. Acta Neuropathol, 2024. Cited by 110 papers, by iCite.
Cite this record
ConductScience Library. Inflammatory aspects of Alzheimer's disease. Papers, record 39196440. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39196440
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Microglia | Major topic |
| Neuroinflammatory Diseases | Major topic |
| Humans | |
| Animals | |
| Inflammation | |
| Astrocytes | |
| Brain | |
| Amyloid beta-Peptides |
Source PubMed
References240
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28467650 | Astrocyte dysfunction in Alzheimer disease. | J Neurosci Res | 2017 | https://conductscience.org/library/papers/28467650 | PubMed |
| 2 | 23770676 | A complex secretory program orchestrated by the inflammasome controls paracrine senescence. | Nat Cell Biol | 2013 | https://conductscience.org/library/papers/23770676 | PubMed |
| 3 | 8673924 | Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. | Nat Med | 1996 | https://conductscience.org/library/papers/8673924 | PubMed |
| 4 | 26436904 | Depletion of microglia and inhibition of exosome synthesis halt tau propagation. | Nat Neurosci | 2015 | https://conductscience.org/library/papers/26436904 | PubMed |
| 5 | 25078115 | When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease. | Ageing Res Rev | 2014 | https://conductscience.org/library/papers/25078115 | PubMed |
| 6 | 22383525 | Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytes. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22383525 | PubMed |
| 7 | 37264120 | Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trials. | Mol Psychiatry | 2023 | https://conductscience.org/library/papers/37264120 | PubMed |
| 8 | 22784036 | Clinical and biomarker changes in dominantly inherited Alzheimer's disease. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22784036 | PubMed |
| 9 | 21040844 | Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. | Neuron | 2010 | https://conductscience.org/library/papers/21040844 | PubMed |
| 10 | 37248300 | Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease. | Nat Med | 2023 | https://conductscience.org/library/papers/37248300 | PubMed |
| 11 | 35379992 | New insights into the genetic etiology of Alzheimer's disease and related dementias. | Nat Genet | 2022 | https://conductscience.org/library/papers/35379992 | PubMed |
| 12 | 7525701 | Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. | J Immunol | 1994 | https://conductscience.org/library/papers/7525701 | PubMed |
| 13 | 34522039 | Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus. | Nat Rev Neurol | 2021 | https://conductscience.org/library/papers/34522039 | PubMed |
| 14 | 20920788 | Regulation of tau pathology by the microglial fractalkine receptor. | Neuron | 2010 | https://conductscience.org/library/papers/20920788 | PubMed |
| 15 | 36453496 | Bidirectional Communication Between Microglia and Astrocytes in Neuroinflammation. | Curr Neuropharmacol | 2023 | https://conductscience.org/library/papers/36453496 | PubMed |
| 16 | 16741123 | Onset and progression in inherited ALS determined by motor neurons and microglia. | Science | 2006 | https://conductscience.org/library/papers/16741123 | PubMed |
| 17 | 26638867 | Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo. | J Alzheimers Dis | 2016 | https://conductscience.org/library/papers/26638867 | PubMed |
| 18 | 34644556 | Microglia: Immune and non-immune functions. | Immunity | 2021 | https://conductscience.org/library/papers/34644556 | PubMed |
| 19 | 27090093 | High Resolution Dissection of Reactive Glial Nets in Alzheimer's Disease. | Sci Rep | 2016 | https://conductscience.org/library/papers/27090093 | PubMed |
| 20 | 34669475 | Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates. | Sci Adv | 2021 | https://conductscience.org/library/papers/34669475 | PubMed |
Cited by90
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939536 | Brain AT1 Receptor Involvement in Cognitive Decline and Neuroinflammation in Streptozotocin-Treated Rats. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42939536 | PubMed |
| 42865804 | Immune-related molecular links between asthma and Alzheimer's disease identified by multi-omics, machine learning and single-cell analysis. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42865804 | PubMed |
| 42835365 | Icariside II protects against neuronal injury by modulating PI3K/AKT-dependent mitochondrial dynamics and apoptosis in Alzheimer's disease models. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42835365 | PubMed |
| 42834042 | Glutamine metabolism in health and disease. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42834042 | PubMed |
| 42819642 | Research advances in red ginseng polysaccharides: preparation, structural characteristics and immunomodulatory effect. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42819642 | PubMed |
| 42818075 | Reducing Neutrophil Sialic Acid Residues Alleviates Cerebral Hypoperfusion in Alzheimer's Models. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818075 | PubMed |
| 42778580 | Hippocampal AdipoR1 regulates the microglial response and delays disease progression in a mouse model of Alzheimer's disease. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/42778580 | PubMed |
| 42775105 | The potential of platelet-rich plasma and PRP-derived biologics for neurological disorders: mechanisms and translational research. | Front Immunol | 2026 | https://conductscience.org/library/papers/42775105 | PubMed |
| 42743169 | Epigenetic control of transposable elements in brain and brain disorders. | Epigenetics | 2026 | https://conductscience.org/library/papers/42743169 | PubMed |
| 42676794 | Astragalus polysaccharide alleviates neuropathology and cognitive deficits by modulating gut microbiota and neuroinflammation in an Alzheimer's disease model. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42676794 | PubMed |
| 42663999 | Transcriptomic Signatures of Microglial Phagocytosis Reveal Diagnostic Markers and Immune Landscape in Alzheimer's Disease. | FASEB J | 2026 | https://conductscience.org/library/papers/42663999 | PubMed |
| 42642009 | Oxytocin as regulator of stress and inflammation in aging. | Neurosci Biobehav Rev | 2026 | https://conductscience.org/library/papers/42642009 | PubMed |
| 42633445 | Novel cell markers with altered expression in brain aging and Alzheimer's disease: A review. | IBRO Neurosci Rep | 2026 | https://conductscience.org/library/papers/42633445 | PubMed |
| 42616215 | Neuroinflammatory and molecular pathways in Alzheimer's disease: mechanistic crosstalk and emerging therapeutic opportunities. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42616215 | PubMed |
| 42597400 | Effects of Curcuma longa extract on cognitive function in healthy participants with subtle cognitive weaknesses within the normal range: a randomized, double-blind, placebo-controlled trial. | Front Nutr | 2026 | https://conductscience.org/library/papers/42597400 | PubMed |
| 42524328 | Pharmacodynamic and stage-dependent therapeutic efficacy of SFRP1 neutralization in a mouse model of Alzheimer's disease. | Alzheimers Dement (N Y) | 2026 | https://conductscience.org/library/papers/42524328 | PubMed |
| 42513102 | Cholesterol at the Center of Alzheimer's Disease: A Unifying Hypothesis on the Pathogenic Mechanism. | Molecules | 2026 | https://conductscience.org/library/papers/42513102 | PubMed |
| 42495541 | Tuberostemonine ameliorates Alzheimer's disease pathology by suppression of the p38 MAPK signaling pathway. | iScience | 2026 | https://conductscience.org/library/papers/42495541 | PubMed |
| 42444707 | Discovery and synthesis of phenylthiophene sulfonamide derivatives with promising anti-inflammatory activity. | RSC Adv | 2026 | https://conductscience.org/library/papers/42444707 | PubMed |
| 42439636 | Human Microglial Molecular Alterations in Aging and Alzheimer's Disease. | Cells | 2026 | https://conductscience.org/library/papers/42439636 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39196440
GET https://conductscience.org/api/papers/v1/39196440/references?page=2